John Carmack, the iconic Dallas game developer, rocket engineer, and VR pioneer, is taking aim now at solving AGI. If successful, his moonshot effort would be a ‘change-the-world-level’ event.
John Carmack, the iconic Dallas game developer, rocket engineer, and VR pioneer, is taking aim now at solving AGI. If successful, his moonshot effort would be a ‘change-the-world-level’ event.
Caris Life Sciences, the Irving-based biotech company, announced Thursday that it closed a senior secured term loan providing up to $400 million in capital from OrbiMed and Braidwell, bringing its funding total since 2018 to roughly $1.7 billion....
The Dallas-based biopharmaceutical company expects to begin testing the drug candidate in a “first in human” trial in mid-2023. The drug was developed using the publicly traded company’s AI/ML drug development platform.
Lantern, in collaboration with the National Cancer Institute, recently published insights on how AI can be used to find new indications for cancer drugs in record times with significant reductions in costs.
Go-To-Green's patented audio-visual system can detect both the sound of a fired gunshot and the pressure change made by a bullet in the air. The system lights up to direct people to the safest exit—and tracks the source of shots.
In North Texas, the system is currently being installed in Anna's city hall, and talks are underway with three school systems and a grocery chain, the startup's CEO told us.
The charitable foundation of Dallas Mavericks owner and serial entrepreneur Mark Cuban—is teaming up with local tech firms to launch its free AI Bootcamps for high school students across North Texas and beyond.
“These young leaders can now participate in the conversation around how AI should be developed and used,” Cuban has said. “We’re giving them a seat at the table.”
Irving-based Pieces, a health care-focused AI company, is teaming up with a Philadelphia firm to accelerate patient identification for a National Cancer Institute colorectal cancer study. Nearly 10,000 participants will be needed across the U.S.
Pieces will use its analytics platform—which combines AI with natural language processing, to “read” through hundreds of thousands of electronic colonoscopy notes and records—to quickly identify patients that meet the study’s criteria.
Dallas-based construction giant Austin Commercial is partnering with Versatile, a California construction tech startup, on the use of CraneView. The hardware connects to cranes "below the hook," measuring key data points to help reduce construction time while increasing the number of loads picked up.
Austin Commercial says it's the first in Texas to use the technology.
Spacee, a computer vision- and AI-powered augmented reality company, has unveiled a new three-person advisory board in a moment that founder and CEO Skip Howard calls “critical.”
InfoVision, a Richardson-based digital transformation and consulting firm, is spinning out its Digit7 business—which focuses on developing customizable and scalable digital solutions through “next-gen” tech—as an independent entity.
Last year, Digit7 set up a 15,000 square-foot “innovation lab” in Richardson. The company also has offices in India.
Arlington-based First Rate, which provides technology and services to wealth management companies, launched its corporate venture arm First Rate Ventures in December. Now it's made its second investment—in New York-based RegAlytics, a regulatory data analytics company.
SMU is investing $11.5 million into a powerful new supercomputing research system featuring an NVIDIA DGX SuperPOD. Connected with the NVIDIA Quantum InfiniBand networking platform in SMU's data center, it will produce a theoretical 100 petaflops of computing power—enabling the university's network to perform "a blistering 100 quadrillion operations per second."
The new capability will supercharge SMU's AI and supercomputing exploration, boosting North Texas' growth as a technology hub.
Parasanti Co-founders James Hancock and veteran Joshua Seagroves both had roots in ranching and farming, making the defense and ag solutions innovator a natural fit. Now the company is ready to continue growing, adding employees and customers, gaining traction in defense innovation, and launching new projects with the Air Force and oil and gas companies.
Tech genius John Carmack has turned to an audacious new challenge: developing artificial general intelligence. The programming innovator believes we’re now half a dozen insights away from achieving AGI, a form of AI that goes beyond mimicking human intelligence to actually understanding things and solving problems....
North Texas’ resident tech genius, John Carmack, is taking aim now at his most ambitious target: solving the world’s biggest computer-science problem by developing artificial general intelligence. That’s a form of AI whose machines can understand, learn, and perform any intellectual task that humans can do....
Dallas- and Fort Worth-based Satori Capital has launched a new investment business focused on “transformational companies developing innovative solutions for mental health.”
Satori Neuro will target companies developing breakthrough treatments and disruptive business models to address “the world’s most critical mental health challenges,” Satori said....
Tech genius John Carmack has turned to an audacious new challenge: developing artificial general intelligence. The programming innovator believes we’re now half a dozen insights away from achieving AGI, a form of AI that goes beyond mimicking human intelligence to actually understanding things and solving problems....
North Texas’ resident tech genius, John Carmack, is taking aim now at his most ambitious target: solving the world’s biggest computer-science problem by developing artificial general intelligence. That’s a form of AI whose machines can understand, learn, and perform any intellectual task that humans can do....
Dallas- and Fort Worth-based Satori Capital has launched a new investment business focused on “transformational companies developing innovative solutions for mental health.”
Satori Neuro will target companies developing breakthrough treatments and disruptive business models to address “the world’s most critical mental health challenges,” Satori said....